MicroRNA‐483 amelioration of experimental pulmonary hypertension is a research paper published in EMBO Molecular Medicine (2020). On theSindex it has a DataRank of 1.9. It has been cited 55 times, with 49 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
1.3
From 44 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 49 citers.
National Natural Science Foundation of China
Grant: 81270349
National Natural Science Foundation of China
Grant: 81670452
National Natural Science Foundation of China
Grant: 81630003
Chinese Academy of Medical Sciences
Grant: 2016‐I2M‐1‐002
Chinese Academy of Medical Sciences
Grant: 2017‐I2M‐B&R‐02
HHS|NIH|National Heart, Lung, and Blood Institute
Grant: K24 HL132105
HHS|NIH|National Heart, Lung, and Blood Institute
Grant: K99 HL135258
Natural Science Foundation of Beijing Municipality
Grant: 7181009
13th Five‐Year Plan—Precise Medicine—Key Research and Development Program—Clinical Cohort of Rare Disease
Grant: 2016YFC0901500
Beijing Nova Programme Interdisciplinary Cooperation Project
Grant: XXJC201805‐Z181100006218125
Chinese Academy of Medical Sciences
Grant: 2017‐I2M‐B&R‐02
FWCI
2.54
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals